ImportantUpdates
Concord Biotech's board approved Q3 financial results.
Concord Biotech LimitedCONCORDBIO · Filed with the exchange
Consolidated net profit reached ₹63.64 Cr, impacted by a ₹3.27 Cr one-time employee benefit charge.
Paritosh Trivedi was also appointed as the new Company Secretary and Compliance Officer.
No comments yet. Be the first.